INDBInternet News Database 2.5 Updated 1 min ago · 393 sources Show or hide images Light or dark

Novel Device Promising in AD Despite Missed Primary Endpoint

Save Like Comments Compare coverage

Summary

A noninvasive audiovisual stimulation device for Alzheimer’s disease misses the primary endpoint in the phase 3 HOPE trial but shows an encouraging signal of benefit in mild disease.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Novel Device Promising in AD Despite Missed Primary Endpoint

    A noninvasive audiovisual stimulation device for Alzheimer’s disease misses the primary endpoint in the phase 3 HOPE trial but shows an encouraging signal of benefit in mild disease.

Comments

Comments need JavaScript.